Teva Pharmaceutical Industries Ltd. (TEVJF)
37.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Teva Pharmaceutical Industries EPS Diluted (Quarterly) : -0.4944 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4944 |
| March 31, 2026 | 0.313 |
| December 31, 2025 | 0.4092 |
| September 30, 2025 | 0.372 |
| June 30, 2025 | 0.2429 |
| March 31, 2025 | 0.1846 |
| December 31, 2024 | -0.1915 |
| September 30, 2024 | -0.3857 |
| June 30, 2024 | -0.7467 |
| March 31, 2024 | -0.1238 |
| December 31, 2023 | 0.4054 |
| September 30, 2023 | 0.0608 |
| June 30, 2023 | -0.7786 |
| March 31, 2023 | -0.1973 |
| December 31, 2022 | -1.171 |
| September 30, 2022 | 0.05 |
| June 30, 2022 | -0.209 |
| March 31, 2022 | -0.8627 |
| December 31, 2021 | -0.1442 |
| September 30, 2021 | 0.2633 |
| June 30, 2021 | 0.1866 |
| March 31, 2021 | 0.0696 |
| December 31, 2020 | 0.1364 |
| September 30, 2020 | -3.968 |
| June 30, 2020 | 0.1273 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.063 |
| December 31, 2019 | 0.1006 |
| September 30, 2019 | -0.2875 |
| June 30, 2019 | -0.6309 |
| March 31, 2019 | -0.0963 |
| December 31, 2018 | -2.852 |
| September 30, 2018 | -0.2682 |
| June 30, 2018 | -0.2367 |
| March 31, 2018 | 1.034 |
| December 31, 2017 | -11.41 |
| September 30, 2017 | 0.5211 |
| June 30, 2017 | -5.934 |
| March 31, 2017 | 0.5703 |
| December 31, 2016 | -1.02 |
| September 30, 2016 | 0.35 |
| June 30, 2016 | 0.20 |
| March 31, 2016 | 0.62 |
| December 31, 2015 | 0.55 |
| September 30, 2015 | 0.12 |
| June 30, 2015 | 0.63 |
| March 31, 2015 | 0.52 |
| December 31, 2014 | 0.80 |
| September 30, 2014 | 1.02 |
| June 30, 2014 | 0.87 |
| March 31, 2014 | 0.87 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
| Purple Biotech Ltd. | 0.4069 |
| Sol-Gel Technologies Ltd. | -1.126 |
| PolyPid Ltd. | -0.3467 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -576.00M |
| Revenue (Quarterly) | 4.15B |
| Total Expenses (Quarterly) | 4.726B |
| Enterprise Value | 56.33B |
| Gross Profit Margin (Quarterly) | 52.07% |
| Profit Margin (Quarterly) | -13.88% |
| Earnings Yield | 1.62% |
| Operating Earnings Yield | 7.54% |
| Normalized Earnings Yield | 4.283 |